Movahedi Naini Said, Sheridan Alice M, Force Thomas, Shah Jagesh V, Bonventre Joseph V
Renal Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Mol Cell Biol. 2015 Nov;35(21):3768-84. doi: 10.1128/MCB.00184-15. Epub 2015 Aug 24.
The G2-to-M transition (or prophase) checkpoint of the cell cycle is a critical regulator of mitotic entry. SIRT2, a tumor suppressor gene, contributes to the control of this checkpoint by blocking mitotic entry under cellular stress. However, the mechanism underlying both SIRT2 activation and regulation of the G2-to-M transition remains largely unknown. Here, we report the formation of a multiprotein complex at the G2-to-M transition in vitro and in vivo. Group IVA cytosolic phospholipase A2 (cPLA2α) acts as a bridge in this complex to promote binding of SIRT2 to cyclin A-Cdk2. Cyclin A-Cdk2 then phosphorylates SIRT2 at Ser331. This phosphorylation reduces SIRT2 catalytic activity and its binding affinity to centrosomes and mitotic spindles, promoting G2-to-M transition. We show that the inhibitory effect of cPLA2α on SIRT2 activity impacts various cellular processes, including cellular levels of histone H4 acetylated at K16 (Ac-H4K16) and Ac-α-tubulin. This regulatory effect of cPLA2α on SIRT2 defines a novel function of cPLA2α independent of its phospholipase activity and may have implications for the impact of SIRT2-related effects on tumorigenesis and age-related diseases.
细胞周期的G2期至M期转换(或前期)检查点是有丝分裂进入的关键调节因子。SIRT2作为一种肿瘤抑制基因,通过在细胞应激下阻止有丝分裂进入来参与该检查点的调控。然而,SIRT2激活以及G2期至M期转换调节的潜在机制在很大程度上仍不清楚。在此,我们报告了在体外和体内G2期至M期转换时多蛋白复合物的形成。IVA组胞质磷脂酶A2(cPLA2α)在该复合物中起桥梁作用,促进SIRT2与细胞周期蛋白A-Cdk2的结合。然后细胞周期蛋白A-Cdk2在Ser331位点使SIRT2磷酸化。这种磷酸化降低了SIRT2的催化活性及其与中心体和有丝分裂纺锤体的结合亲和力,从而促进G2期至M期转换。我们表明,cPLA2α对SIRT2活性的抑制作用影响多种细胞过程,包括K16位点乙酰化组蛋白H4(Ac-H4K16)和Ac-α-微管蛋白的细胞水平。cPLA2α对SIRT2的这种调节作用定义了cPLA2α一种独立于其磷脂酶活性的新功能,并且可能对SIRT2相关效应在肿瘤发生和年龄相关疾病中的影响具有启示意义。